Reoperation Rate 4 Percent for Mesh-Based Prolapse Surgery

Share this content:
Reoperation Rate 4 Percent for Mesh-Based Prolapse Surgery
Reoperation Rate 4 Percent for Mesh-Based Prolapse Surgery

WEDNESDAY, June 15, 2016 (HealthDay News) -- For women undergoing mesh-based prolapse surgery, the reoperation rate is 4.0 percent at a median of 1.17 years, with reduced risk for patients of surgeons with very high volume, according to a study published in the July issue of Obstetrics and Gynecology.

Erin C. Kelly, M.D., from the University of Western Ontario in London, Canada, and colleagues conducted a retrospective, population-based cohort study involving all women who underwent mesh-based prolapse procedures between 2002 and 2013. The authors examined the proportion of women who underwent surgical revision of the mesh, with the primary exposure of surgeon volume. Data were included for 5,488 women who underwent mesh implantation by one of 368 unique surgeons; median follow-up was 5.4 years.

The researchers found that at a median of 1.17 years after implantation, 4.0 percent of women underwent mesh reoperation. Patients of very high-volume surgeons had a lower risk of reoperation for complications (3.0 versus 4.8 percent; adjusted hazard ratio, 0.59). Younger age, concomitant hysterectomy, blood transfusion, and increased medical comorbidity correlated with vaginal mesh reoperation in multivariable modeling.

"Approximately 5 percent of women who underwent mesh-based prolapse surgery required reoperation for a mesh complication within 10 years," the authors write. "The risk of reoperation was lowest for surgeons performing 14 or more procedures per year."

One author disclosed financial ties to Astellas Canada.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

Study Finds 31 Percent Use No Opioids After Surgery

Study Finds 31 Percent Use No Opioids After ...

At discharge, 92.2 percent of patients received an opioid prescription; nearly 63 percent unused

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs May Have Lower Diagnostic Accuracy for Melanoma

PAs diagnose fewer melanomas in situ, perform more skin biopsies per case of skin cancer diagnosed

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

AAN: Neuromodulation Therapy Gives Relief From Hand Tremor

Non-invasive neuromodulation therapy using a custom stimulation pattern safe for essential tremor

is free, fast, and customized just for you!

Already a member?

Sign In Now »